• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

Kyochon Chicken Launches App Discount Campaign to Support the National Team

#Kyochon F&B is holding a discount promotion on its signature menu items via the Kyochon Chicken app to coincide with the national soccer team’s match schedule. Kyochon F&B announced that it wi…
  • 2026-06-12 09:17:45
  • SIN SOO-JUNG
SMEs

100 Companies Aspiring to Become Mid-Sized Enterprises Gather… Strengthening Networking Through Growth Program

The Ministry of SMEs and Startups and the Korea SMEs and Startups Agency (KOSME) organized an event for companies participating in the “Leap Program” to share know-how and propose ways to improve thei…
  • 2026-06-12 09:12:15
  • Kim Se-yeon
Lifestyle

Nongshim Launches Power O2 Mango Flavor Targeting the Summer Beverage Market

Nongshim is set to target the summer beverage market with a new oxygen-infused drink featuring mango flavor. #Nongshim announced on the 12th that it will launch "Power O2 Mango Flavor" on the 1…
  • 2026-06-12 09:11:23
  • SIN SOO-JUNG
Lifestyle

Samyang Foods Selected as 'Best Korea Brand' for Two Consecutive Years…Buldak’s Competitive Edge

Samyang Foods has been named to Interbrand’s “Best Korea Brands” list for the second consecutive year, driven by its global growth led by its flagship brand, Buldak.#Samyang Foods announced on the 12t…
  • 2026-06-12 09:02:28
  • kim mi-kyung
Lifestyle

CJ CheilJedang’s Brand Value Reaches 1.1866 Trillion Won…Ranked No. 1 Among Consumer Goods Companies

CJ CheilJedang has once again demonstrated its competitiveness as a leading brand in the domestic food industry by being named to the “2026 Best Korea Brands” list.#CJ CheilJedang announced on the 12t…
  • 2026-06-12 08:54:38
  • kim mi-kyung
Lifestyle

"From Diagnosis to Treatment"... FutureChem: What Is the Strategy to Complete the Puzzle with Therapeutic Radiopharmaceuticals?

#FutureChem has decided on a final round of fundraising ahead of its full-scale revenue generation and has secured a cash cow, allowing it to accelerate the development of FC705, a radiopharmaceutical…
  • 2026-06-12 08:21:05
  • Kim Jinsoo
Lifestyle

NextBio’s ‘Nexpire F’ Demonstrates Potential for Endless Evolution... Proven by a Series of Clinical Successes

#NextBioMedical is reshaping the medical device market landscape, centered on its knee osteoarthritis treatment, NexSphere F. This is because NexSphere F, which started as a treatment for knee osteoar…
  • 2026-06-12 08:21:03
  • YU JIN-HEE
Lifestyle

Dasan Pharmaceutical Accelerates CDMO Push in Japan... "Full-Scale Supply of Flagship Pellet Product Begins"

Dasan Pharmaceutical has successfully completed an on-site inspection by Japan’s Pharmaceutical and Medical Devices Agency (PMDA), accelerating its efforts to penetrate the local market and expand its…
  • 2026-06-12 08:21:02
  • YU JIN-HEE
Lifestyle

Vivozon Pharma and Lunit Rally on Commercialization and Nvidia Tailwinds [K-Bio Pulse]

Following a broad rally across Korea’s pharmaceutical and biotech sector the previous day, trading on June 10 shifted toward stock-specific momentum. Vivozon Pharm surged nearly 10% on expectations fo…
  • 2026-06-12 08:01:02
  • SONG YOUNG-DOO
Lifestyle

Bibozon Pharma and Lunit Rise in Tandem... Expectations for Commercialization and NVIDIA-Driven Expansion [Bio Spotlight]

Following a broad rally across the pharmaceutical and biotech sectors the previous day, the market on the 10th saw a differentiated trend centered on stocks with individual momentum. Vibozon Pharmaceu…
  • 2026-06-12 08:01:02
  • SONG YOUNG-DOO
prev 31 32 33 34 35 36 37 38 39 40 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English